Project Grant R01HL181092
Award Date 8/17/26
Completion Date 4/30/31
Dollars Obligated $565K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60637, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded Women & Infants Hospital of Rhode Island $244,569 on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a single-site randomized controlled trial piloting the feasibility and efficacy of postpartum enalapril treatment for cardiovascular protection in women with a history of preeclampsia. The trial will enroll women within the hospital's remote blood pressure management program to assess whether...
- The National Heart Lung and Blood Institute awarded The Ohio State University $170,964 under the Cardiovascular Diseases Research program (CFDA 93.837) on August 15, 2026, to characterize hypertension after pregnancy through patient-centered research. The project, titled CHAPTER (Characterizing Hypertension After Pregnancy Through Patient-Centered Research), addresses postpartum hypertension affecting over 18% of women in the first postpartum year and associated with a threefold increase in...
- The National Heart, Lung, and Blood Institute awarded the University of Alabama at Birmingham $136,511 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support the PRIME Study—Preeclampsia Risk Identification, Mitigation, and Prevention in Type 2 Diabetes Through Research and Mentorship. The award funds research and structured mentoring integrated with the ongoing CGM2 trial, which enrolls 564 pregnant patients with type 2 diabetes. The PRIME Study will...
- The National Heart, Lung, and Blood Institute awarded Trustees of Boston University (doing business as Boston University Medical Campus) $1,303,658 on May 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to study postpartum hypertension, its role in recurrent hypertensive disorders of pregnancy, and modifiable intermediates including blood pressure management and breastfeeding practices. The project grant R01HL183084 runs through January 31, 2031, with performance in...
- The National Institute of Child Health and Human Development awarded the University of Kansas Medical Center Research Institute, Inc. $535,183 on August 26, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to evaluate the Healthy Outcomes for Pregnancy and Expected Parents (HOPE) intervention, a multilevel, patient-centered approach to prevent hypertensive disorders of pregnancy in high-risk populations. The HOPE intervention addresses barriers to...
- The National Heart, Lung, and Blood Institute awarded Brigham & Women's Hospital Inc. $908,994 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to test implementation strategies for electronic health record-based interventions to improve hypertension control in primary care settings. The project builds on the recipient's prior NIH-funded REDUCE-BP trial, which enrolled 49,210 patients and 560 primary care providers and demonstrated that multi-component...
- The National Heart, Lung, and Blood Institute awarded the University of Alabama at Birmingham $754,413 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a randomized controlled trial of remote blood pressure monitoring, pharmacist-led telehealth medication management, and automated text reminders integrated into an emergency department transitional care clinic model for hypertensive patients. The trial, titled REMAP-BP (Remote Blood Pressure...
- The National Heart, Lung, and Blood Institute awarded the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center $161,500 on August 20, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support planning activities for a future multisite cluster randomized trial on hypertensive disorders of pregnancy prevention in safety-net clinics. The award funds a preparation phase to evaluate the feasibility and acceptability of implementation intervention...
- The National Institute for Minority Health and Health Disparities awarded The University of Chicago $830,875 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and evaluate a primary care model addressing interconception care—healthcare services provided after pregnancy to support optimal outcomes in future pregnancies. The award supports research on how primary care providers can address treatable chronic diseases including diabetes,...
- The National Institute of Child Health and Human Development awarded Emory University $426,948 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and validate artificial intelligence models that integrate electronic health record data to identify clinically meaningful subtypes of hypertensive disorders of pregnancy and predict disease onset before clinical diagnosis. The project will model longitudinal physiological changes and...